NBCF_25years_timeline_v2.1 Gio INCREASINGSURVIVAL RATES BREAST CANCER RESEARCH PROJECTS WERE FUNDED MILLION FUNDRAISERS THROUGHOUT AUSTRALIA EARLY DIAGNOSIS NEW TREATMENTS

This year NBCF is celebrating 25 years of research and fundraising milestones. This includes the development of new drugs, treatments and screening methods. These will help to improve the detection of breast cancer and save lives. Since NBCF’s inception, fundraisers and supporters have helped us to raise $162 million towards 514 life-changing research projects.

Together, with the community’s support, we’ve made an undeniable impact on the face and future of breast cancer in Australia.

Thank you for your support.

1994

The Beginning of an Icon

The National Breast Cancer Foundation (NBCF) is founded.

1994

First Corporate Partners Secured

David Jones and Estee Lauder Companies join as Corporate Partners. Since this time hundreds of organisations have contributed over $60 million dollars to the National Breast Cancer Foundation.

1994

Stats at the Start

The five year survival rate for breast cancer is 76 per cent.

Breast cancer is no stranger to Renee’s family. Both her mum and grandmother have the diseases with two very different outcomes, her grandma died when just a little was understood about the disease, but her mum Irene, thankfully was treated successfully and a decade on she is cancer free. However, this has given the young Renee a lot of tension and stress every time she is going through a medical check-up. Due to her family history, she decided to take a genetic test and this showed that Renee has an 80 per cent change of developing breast cancer in her lifetime. Although it wasn’t the news she wanted to hear, this provided her the certainly she needed to make an important decision about her life and future. She ultimately chose to have a preventive surgery (removal and reconstruction) to reduce her risk.

Thanks to research, genetic testing has become a powerful tool for making decisions about the health and wellbeing in the future, and young women like Renee can live a different life free of breast cancer.

1997

NBCF FUNDS MAJOR FAMILIAL BREAST CANCER PROJECT

NBCF funds the establishment of KConFab, a national and international resource to study familial breast cancer. Through kConFab, researchers in Australia and worldwide can now have access to 20 years of accumulated biological samples linked to extensive data to help determine the lifestyle and molecular causes of breast cancer. This has led to new strategies for prevention and new and better treatments.

1998

MDC LAUNCHES

Women in Super establishes the Mother’s Day Classic (MDC), now the major annual fundraising event for breast cancer research in Australia.

2000

Breast Cancer Research Up in Lights

The Global Illumination campaign is launched with Estée Lauder Companies and iconic sites around Australia glow pink.

“Throughout my time working with NBCF, I have been overwhelmed by the generosity of the thousands of women and men who raise or give funds for us to direct to the very best research.”

2001

Sarah Murdoch becomes NBCF’s Patron

“The group and I have been volunteering since 1998, and have formed great bonds and friendships over this time. The volunteering role at NBCF was a great opportunity for us to continue to work together and help a great cause. We always have lots of laughs and it’s very social, which is so beneficial for us. We also find it so rewarding when we see the donations coming through and the difference that this makes to people with breast cancer.”

- Peter Thomson (member of Team G and recipient of an Order of Australia Medal in 2018)

2001

Team G Start Volunteering

Named after Bill Galvin, their dedicated team leader who has since passed away, Team G decided to volunteer at NBCF to keep active, contribute to research and honour Bill’s memory. You will find them every Wednesday in the NBCF office at a table named in their honour; opening mail, having a chat and occasionally sharing a Tim Tam.

2002

PINK RIBBON MAGAZINE IS BORN

Pink Ribbon magazine, Australia’s first ever women’s magazine focused on breast cancer, hits newsstands.

“Ford’s global commitment towards funding breast cancer research has helped the National Breast Cancer Foundation (NBCF), by raising awareness and much needed funds to improve how breast cancer is diagnosed, managed and treated. By funding only world-class research, Ford is helping NBCF work towards their goal of zero deaths from breast cancer by 2030.”

2002

NBCF Partners with Ford

Over time Ford has raised $1.7 million for NBCF and breast cancer research.

2003

“The Shepparton Pink Ribbon Brunch has continued to grow each year and is now the largest function attended by women in Greater Shepparton and the second largest breakfast for the National Breast Cancer Foundation.”

– Karen Gill

PINK RIBBON BREAKFAST LAUNCHES

NBCF launches its first-ever Pink Ribbon Breakfast campaign. This has since raised over $20 million for breast cancer research.

2003

“As a brand, NBCF is a cause that is very close to our hearts. Not only are we very passionate about raising awareness and funds for breast cancer, we’re also very proud to continue our ongoing support for such an important organization.”

- ghd Australia and New Zealand Managing Director Ludovic Dellazzeri

NBCF Partners with GHD

The long-standing collaboration between ghd and NBCF has raised more than $4.2 million for breast cancer research over the past 15 years.

2004

PROFESSIONALS PARTNERSHIP

The Professionals Real Estate group have been partners with NBCF since 2004 and have raised over $3.3 million dollars for breast cancer research. Each year Professionals members get together and hold fundraising events in their local community across Australia. They also make a donation to breast cancer research for each home sold.

2004

NATIONAL ACTION PLAN LAUNCHES

NBCF releases Australia’s first-ever National Action Plan for breast cancer research and funding. Up until this time, Australia lacked a formal strategic plan for breast cancer research. The plan addresses the need for breast cancer funding and research to be coordinated at a national level and encourage collaboration at all levels – between researchers, advisors, community members and other key breast cancer organisations.

"In 2004 I set out to make a difference, and everyday people tell me their stories and it makes me proud to know that in the past fifteen years, thanks to research, there are now better outcomes and more answers for the 1 in 8 women and 1% of men affected by a breast cancer diagnosis. I also am extremely proud of the researchers that the NBCF has funded. Their ground breaking work has been possible thanks to the support of so many generous folk in our communities, and also due to work of volunteer fundraisers like myself who donate their time and resources across this nation to support the NBCF's aspirational goal of zero deaths by 2030"

2004

LONG-TIME FUNDRAISER JUDI ADAMS COMES ONBOARD

Taking on the voluntary role of chair of the Hobart Committee of NBCF, Judi immediately began rallying support, engaging sponsors and hosting events, such as The Pink Cup, Global Illumination events later to become Luminate Hobart, Pinktober, Shannons Take Your Tops Off for Breast Cancer Research,. Since then, she’s staged breakfasts, luncheons and gala dinners, sporting events and car shows, raising a staggering $400,000 profit – with every cent going to breast cancer research. Judi was recognised for her long term commitment to the NBCF by receiving the NBCF Patron’s award in 2013. She also has been awarded the National Australia Day Council Australian of the Year –TAS Local Hero in 2018, and has extended her role as a passionate advocate for breast cancer awareness participating as a committee member of Mother’s Day Classic event in Brisbane and many others community events across Australia.

“NBCF and their work helped my recovery and, over time, I was able to understand that I would survive and survive well. I can’t be grateful enough for the support of their research and shared commitment to the cause. I remember watching those women and men who nervously brace themselves in my training sessions to first tell their stories, and then blossom to become far more competent and effective in getting their message across by the end of the training.”

2005

THE SPEAKERS NETWORK IS BORN

NBCF establishes the Speakers Network, a community of over 100 Australian women and men who have been impacted by breast cancer. This remarkable group share their story and how breast cancer research has helped them. Speakers Network trainers Amanda Maltabarow and Chris have played an integral role in the program’s success.

When Sandra Hudson was diagnosed with aggressive breast cancer in 2008, she was a wife, mother of two and juggling a busy career with family commitments. Sandra recalls that laughter was really important while she was going through surgeries, blood and palette transfusions, radiation treatments, chemotherapy “boot camp” and its terrible side effects. She was post-menopausal at the age of 39.

She was nicknamed the ‘Chosen One’ by her sisters, which has stuck to this day.

“Everyone’s journey is different and because of many friends and family, mine was not travelled alone. I believe you need to have a positive outlook and empower others to have a voice when it comes to health choices we are faced with making.” – Sandra Hudson.

2005

TOOLKIT DEVELOPED FOR YOUNG WOMEN

NBCF funded researchers Professor Martha Hickey and Dr Belinda Thewes develop the first-ever comprehensive information toolkit aimed at young women with breast cancer dealing with the impact of menopause related symptoms of treatment.

Di’s top 5 tips for hosting a fantastic event!
1. Set yourself a "challenging" goal
2. Plan, plan and plan
3. Be creative with your event theme
4. Don't be afraid to ask for help from friends and family
5. Always send a personalised thank you

2005

FUNDRAISING & EVENTS EXTRAORDINNAIRE DI FINCHER STARTS SUPPORTING NBCF

Di Fincher and her team hold many events throughout the year to support NBCF: from movie nights, to health days and networking events.

The biggest event on the calendar is her incredible Pink Ribbon Breakfast which she holds every October at Flemington Victoria.

“Prior twin studies have suggested that in theory there is a genetic link between mammographic density and breast cancer.. For the first time, we have been able to identify some of the genetic faults involved. Finding that several genetic faults linked to breast cancer are also linked to mammographic density could help explain some of the biological reasons why women of the same age differ so much in their risk of developing breast cancer.”

2006

IDENTIFYING BREAST CANCER RISK IN TWINS

Professor John Hopper from the University of Melbourne conducts an important study on twins that showed that genetic factors play a major role in explaining why women of the same age have different mammographic densities.

The work has since gone on to show that genetic factors appear to explain about 60% of the wide variation in mammographic density, and has provided important clues about the genes driving breast cancer risk.

2006

FIRST BREAST CANER TISSUE BANK STARTS

NBCF funds the establishment of the first Australian Breast Cancer Tissue Bank at the Westmead Institute for Medical Research, with collection centres and affiliate sites distributed across Australia. An important resource to support research, the overall aim of the Tissue Bank is to improve knowledge about the disease and manage breast cancer in the future.

2006

NEW RESEARCH FINDING REDUCES INVASIVE SURGERY

To reduce the risk of breast cancer spreading, surgeons can remove most of the armpit’s lymph glands, an invasive procedure which has since been linked to complications. For this reason NBCF funded research, overseen by Professor Grantley Gill and Dr Neil Wetzig from the University of Sydney, which led to the development of a new technique called “sentinel node biopsy” (SNB). SNB involves locating and removing the first lymph gland(s) that a cancer may spread to. If no signs of disease are seen, the remaining glands need not be removed. In this way, many women may avoid the risks of more complex surgery.

2007

Reflecting on the ups and downs of the last 15 years, Lisa says “I often think being a business owner is the best therapy you could ever have, It’s definitely a great way to learn your weaknesses, face your fears, overcome your imaginary obstacles, and test yourself to the farthest limits."

THE BUSINESS WOMEN, LISA POULOS STARTS AS AN NBCF AMBASSADOR

The well-known PR personality Lisa was affected by breast cancer, has her own story of breast cancer when she was diagnosed in 2007. Lisa has shown her passion for breast cancer research supporting the National Breast Cancer Foundation through her products and her strong personal relationship.

2007

"By volunteering I dedicate my time to the memory of my best friend Sed, who died in October 2014. I also feel like I make a valuable contribution to the community, learn new skills and improve my own health and well-being. We are all one big family! Most importantly it reduces the administration cost of the foundation, so that more funds can be channeled into essential research grants."

LONGEST SERVING VOLUNTEER STARTS

Angela Miller, NBCF’s longest-serving volunteer, starts her volunteering role at NBCF. Angela volunteers in memory of her best friend Sue who died in October 2014. She is also driven by close family and friends who have experienced breast cancer. This includes her niece, who was unexpectedly diagnosed at 34. Her knowledge and experience are invaluable to our staff and community alike.

2007

Having been diagnosed with breast cancer at the age of 38 and then again when she was 46, Robyn says “it is due to research undertaken prior to my diagnoses that found ways to detect and treat breast cancer that I survived the disease, both times! So my time to give back to life-saving research. I also know of to many women who were not as lucky as me and the disease took their life. There has been some incredible discoveries which has lessened the impact for many women, but there still a lot more to be done.

There are too many women being diagnosed with the disease and we still lose too many women to this disease. I also have a daughter and just recently a granddaughter; needless to say she is now a huge driving force to continue to fund breast cancer research, because it is research that will unlock the mysteries that surround breast cancer to ensure no more loved ones lose their loved ones to the disease”. That is why I support the NBCF."

STAR FUNDRAISER ROBYN CAMERON JOINS NBCF

The Pink Ribbon Cup Raceday is the largest fundraising event held at the Goald Coast Turf Club in Queensland and the Australia’s largest community fundraiser for NBCF. This year celebrates the 11th anniversary. This must attend fundraising event on the Gold Coast raised $90.503 in 2016, and in 2017, raised a record breaking of $117,130 for life-changing breast cancer research with the generosity donations of the Gold Coast community. The woman behind this incredible day is Robyn Cameron. Robyn is not only the founder of the Pink Ribbon Cup Raceday, she has been the driving force behind many committees including the Global Illumination Gold Coast Committee, the Gold Coast Fundraising & Volunteer Committee and the Mother’s Day Classic Gold Coast Committee.

Tania was diagnosed with HER2 positive breast cancer in 2005 when she was 32 years oldnd a busy mother of three children. She and her husband owned and operated a dairy farm in a rural community about one hour from Adelaide.

“I found the lump when my 2 year old daughter was having a bad night and I had been getting up for her on a 1/2 hourly - hourly basis. I decided to do a self-check and found the lump” said Tania. Within 2-3 weeks, Tania was in the hospital having surgery. She said, she was lucky enough to get a great private surgeon, who was registered with her local hospital.

2009

PBS APPROVES HERCEPTIN

The Pharmaceutical Benefits Scheme (PBS) approves Herceptin for early stage HER2 positive breast cancer. Caused by the over-production of HER2 protein, HER2 positive breast cancers grow fast, spread early and often relapse quickly when treated. Subsequently, the PBS approved Herceptin for Australians with advanced HER2 positive breast cancer. This has resulted in a 30% increase in the survival of HER2 + breast cancer patients. However, 15-20% of HER2+ breast cancer patients do not respond to Herceptin. Further, 50% of HER2+ patients become resistant to Herceptin. Numerous NBCF researchers are investigating new ways to make Herceptin-resistant tumours respond to Herceptin to make the treatment more effective.

2010

REGISTER4 LAUNCHES

NBCF launches Register4, Australia’s first online resource where the community can participate in and fast-track research.

“ME has been a proud partner of the National Breast Cancer Foundation since May 2011 when ME and the NBCF launched the Pink Debit Mastercard, where ME donates one cent for each purchase made with the card. Since 2011, ME has donated more than $1M towards breast cancer research. ME understands the significance of the National Breast Cancer Foundation’s work and appreciates the importance of research in helping beat breast cancer”.

2011

ME BANK PARTNERSHIP FORMS

Over the course of the partnership, ME Bank has raised close to one million dollars for NBCF.


2011

CHARTERED ACCOUNTANTS PARTNERSHIP BEGINS

Chartered Accountants began their partnership with NBCF by holding their Annual High Tea Debate, which is now in its 7th year and raises in excess of $25,000 per year. The company has also participated in two of NBCF’s Bridge to 2030 events and have been regular supporters of the Real Men Wear Pink and Go Pink campaigns.

2012

"There is more hope for diagnosing and treating breast cancer thanks to new technologies like this. Equipping health professionals with the latest tools will ensure they are able to treat patients with far more accuracy.”

– Professor Sarah Hosking, CEO, NBCF

DR BRENDAN KENNEDY DEVELOPS WORLD-FIRST SMART SURGICAL GLOVE

NBCF funded research Dr Brendan Kennedy and his team at the Harry Perkins Institute of Medical Research in WA develop a world-first 3D printed finger-mounted optical imaging probe to remove cancerous cells during breast cancer surgery. Currently, it is difficult for surgeons to understand where cancer tissue ends and where normal tissue starts when performing surgery. Dr Kennedy’s smart surgical glove will ensure that the entire tumour is removed during initial surgery, helping breast cancer patients avoid further operations.

2013

4 INGREDIENTS COMES ONBOARD AS A CORPORATE PARTNER

4 Ingredients have raised over $260,000 for NBCF from the sale of cookbooks and fundraising events.

2013

Jennie Ellis was first diagnosed with breast cancer in 1997 and had all her lymph nodes removed to check for cancer cells. Even though the surgery not found any breast cancer cells, Jennie was left with a lymphedema; a permanent and painful condition caused by the invasive surgery.

Ten years later, her sister in-law Cheryl, was diagnosed with breast cancer. She hasn’t had lymphedema thanks to the advance of research at that time that left her lymph nodes almost intact after a less invasive procedure.

At Jenni’s time, removing all lymph nodes was the standard treatment and women were just expected to put up with lymphedema, as part of the side effects.
“I’m happy that research has meant my sister-in-law and many other women don’t have to accept lymphedema as part of their life.”

– Jennie Ellis

NBCF RESEARCH LEADS TO LYMPH SLEEVE INNOVATION

One-third of Australian women newly diagnosed with invasive breast cancer will develop breast cancer-related lymphedema or swelling of the arm (BCRL). To help alleviate this, NBCF funded researcher Professor Julie Steele from the University of Wollongong led an innovative project to develop a world-first Lymph Sleeve made from ‘smart’ materials that mimics the experience of self-massage. Designed for women to wear daily, it helps to boost the effectiveness of other treatment such as laser therapy, medication and massage. As a result of Professor Steele’s research, the Lymph Sleeve is now being patented for commercialisation.

2013

RESEARCH BREAKTHROUGH: TAMOXIFEN REDUCES RISK OF BREAST CANCER RECURRENCE

NBCF-funded research led by Professor John Simes from the University of Sydney reveals that tamoxifen can reduce the risk of recurrence in women that are high risk of getting breast cancer by up to one-third. This important discovery has helped to reduce breast cancer relapse rates, while also reducing the significant health and economic costs of recurrent disease.

2013

NBCF LAUNCHES WORLD-FIRST IMPACT REPORT

NBCF publicly releases a world first, an independent evaluation of the impact of its program of breast cancer research called the Health Economics Research Group (HERG) Evaluation Report. Conducted by Brunel University in the UK, the HERG Report found that NBCF-funded research has had significant impact in key areas such as policy and decision making, development of new drugs and diagnostics, changes in clinical practice and gains in health and quality of life for women and men affected by breast cancer.

2015

THE PR PERSONALITY, ROBYN FOYSTER, STARTS RAISING AWARENESS FOR BREAST CANCER RESEARCH

Robyn has had a successful career as a PR personality in Queensland directing g and editing magazines as Women’s Weekly, the Carousel Magazine, Women Love Tech and Game Changers.

During her years as an editor and publisher, Robyn published many stories including cover stories profiling women with breast cancer and was actively involved in promoting the work of NBCF, particularly in October.

One of the many stories she published was far more personal. It was the story of her mother, Dr Jacqueline Kerr, who has been affected by breast cancer and has remained involved with NBCF for many years raising awareness for breast cancer research for more than ten years.

2015

“Sadly, we all have been touched by breast cancer, albeit directly or indirectly. It is a problem that will not go away on its own. And statistics of women, with no history of breast cancer in their families, being diagnosed every day is rising. I admire the tenacity and single-mindedness of the NBCF’s goal - that being; zero deaths from breast cancer by 2030. I believe this will only be achievable through the funding of world-class breast cancer research.”

- Sancha Brahimi

NBCF LAUNCHES CIRCLE OF 10 SYDNEY

NBCF’s ‘Circle of 10’ is a philanthropic initiative that brings together a group of influential women who are passionate about raising funds for breast cancer research. The group select an NBCF’s breast cancer research projects to be funded over two years, helping to accelerate leading Australian breast cancer research to stop deaths from breast cancer and leave a legacy for future generations.

2015

NEW FUNDRASING CAMPAIGN LAUNCHES

NBCF launches ‘Real Men Wear Pink’, a campaign that raises awareness about the impact of breast cancer on Australian men, both indirectly and directly. This is later renamed as Go Pink (launched in 2018).

2015

FIRST-EVER CHINA TREK RAISES $300,000 FOR BREAST CANCER RESEARCH

The first-ever Steps Towards Research: Great Wall of China Trek raises close to $300,000 for NBCF. An energetic group of 44 women and men trekked the Great Wall to raise funds for life-changing breast cancer research, challenging themselves, seeing the amazing scenery and creating life-long friendships and unforgettable memories along the way.

After her aunt was diagnosed with breast cancer, Susan McHaffie hoped her small idea would encourage other airlines to show their support to the cause.

“Together with Qantas, it is my goal to raise $20,000 for breast cancer research. I hope by next year I’ll walk past a pilot I don’t know in an international airport wearing pink epaulettes in support of breast cancer research. We believe that research is the key to eradicating the disease, and credit research with the many advances that have been made in breast cancer care and treatment over the past few decades.”

2016

QANTAS LAUNCHES FLYPINK

Qantas joins forces with NBCF for Flypink, an employee engagement initiative held during October to raise funds for breast cancer research. The ongoing campaign has grown in strength every year through the strong support of the Qantas employee’s enthusiasm for the cause, raising over $150,000 in its first 2 years.

2016

RESEARCH INNOVATION: 3D TUMOUR MODELS FOR TARGETED TREATMENTS

NBCF funded researcher Professor Dietmar Hutmacher from the Queensland University of Technology and his team developed a new gel made out of 3D printable material (called hydrogel) that mimics human tissue. They are currently using this as a ‘bioink’ to print 3D ‘microenvironments’ or models of a tumor to test different anti-cancer drugs. This will pinpoint an individualised treatment that will hit only the cancer cells, cutting down the process of finding a personalised treatment for breast cancer down to a week or two. As a result of this work, clinical trials are underway in Europe, USA, India and Singapore.

Tracy Ryan was diagnosed with breast cancer in 2012. Years later, she was diagnosed with metastatic breast cancer. Since her first diagnosis, she joined the NBCF Speakers Network to raise awareness about breast cancer and help young women affected. Tracey says that she has been shocked and saddened to see so many young women, including women with small young children, go through breast cancer. Her journey still continues, but she has found a way to cope with the disease becoming involved and helping others who have crossed thought breast cancer.

2016

NEW DRIVER DISCOVERED TO HALT BREAST CANCER SPREAD

NBCF funded research Dr Samantha Oakes and her team from the Garvan Institute of Medical Research identify a new driver in the spread of breast cancer to other tissues. The research team, showed for the first time that, well-known ‘survival protein’ (MCL-1) is important in the spread (metastasis) of mammary tumours – and that blocking MCL-1 can decrease cancer spread. This is a significant development that paves the way for possible future combination therapies to be developed that may combat metastatic breast cancer.

2016

PROGRESS FOR BREAST CANCER STATS

The 5-year survival rate for breast cancer reaches all-time high of 90%.

2016

"I am willing to push my body to its limit to help fight this disease and prevent more lives being lost.”

JAKE WARD GOES THE DISTANCE FOR BREAST CANCER RESEARCH

Fundraiser Jake Ward runs a mammoth 1500km from the Gold Coast to his hometown of Cranbourne in Victoria and raises $50,000 for NBCF. Upon his arrival he proposes to his girlfriend Jess (who says yes).

2016

“In partnership with NBCF, we have harnessed our network of branches to help educate communities across Australia. As a not-for-profit health fund, who has helped more than 7,000 through breast cancer in the last five years, we understand the value of knowledge,”

-Jenny Williams, Chief Marketing Officer, HCF

HCF Partners With NBCF & Gets ‘Hands On’

HCF partners with NBCF and launches “Hands On” for Breast Cancer Awareness Month in October. Hands On is an education initiative designed specifically to teach Australians what the possible signs of breast cancer feel like to help aid awareness. The integrated campaign is brought to life through experiential activations, media, digital, PR, in branch and social media.

2017

DIAGNOSIS RATES CLIMB

Breast cancer becomes the most commonly diagnosed cancer in Australian women.

2017

“The longer duration of the Endowed Chair funding gives my team, my collaborators and I a unique opportunity to pursue bold and more impactful projects, with the confidence to pursue our research agenda, which ultimately aims to improve the lives of breast cancer patients. This forms the bedrock of my commitment to research.”

NBCF LAUNCHES AUSTRALIAN-FIRST 10 YEAR RESEARCH GRANTS

NBCF announces its new Endowed Chairs research program, an Australian-first ten year grant scheme for breast cancer research. The longer duration of the grants gives Australian researchers the focus that they need for the next big breakthrough in breast cancer research. Professors Elgene Lim and Sherene Loi are appointed as NBCF’s first-ever Endowed Chairs.

2017

“On behalf of our team, I want to thank both the NBCF and the Movember Foundation for supporting this new research project, which has the potential to change the way breast and prostate cancers are treated. This collaborative funding will make a huge impact on our research, with the end goal being to improve and save the lives of those affected by breast and prostate cancer.”

TOP CHARITIES UNITE FOR NEW GRANT TARGETING BREAST AND PROSTATE CANCER

NBCF joins forces with the Movember Foundation to launch the first-ever Breast and Prostate Cancer Linkage Grant. The new grant funds research that jointly targets breast and prostate cancer research. This is awarded to Professor Wayne Tilley from the University of Adelaide for his research into a new treatment path targeting breast and prostate cancer that revamps the traditional method of hormone deprivation therapy (depriving the body of sex hormones oestrogen and testosterone).

“As the NBCF is 100% community funded donations, support and fundraising initiatives like Bridge to 2030 are essential to drive the new ideas and innovations needed in breast cancer research while also enabling our researchers to continue their important work.”

– Professor Sarah Hosking, NBCF CEO

2017

NBCF LAUNCHES BRIDGE TO 2030

NBCF hosts Bridge to 2030, a new fundraiser Australian corporates and community members that gives them the opportunity to climb Sydney Harbour Bridge on 18 May to ‘bridge the gap’ in breast cancer research funding. The event raised over $170,000 to help keep breast cancer researchers on the road to discovery.

Sarah was diagnosed with breast cancer at the age of 32 when she was enjoying being a first-time mother to her 16-month old daughter. Although her grandma died of breast cancer, doctors didn't recognize the family link, as her grandma was in her 80’s. Sarah decided to take the BRCA blood test and this showed unfortunately that she carried the faulty BRCA1 gene and 72% risk of developing breast cancer again in her lifetime. In 2004 she took the hard decision to have a preventive double mastectomy. Fortunately, in 2006, she gave birth to a miracle baby girl Lila and she feels happy to have two beautiful daughters to look after.

2017

NEW MEDICARE REBATE TO TEST FOR BRAC1 AND BRAC2 GENES

NBCF welcomes the news of a new Medicare rebate for Australians diagnosed with breast or ovarian cancer to test for the BRAC1 and BRAC 2 genes. NBCF funds some of Australia’s finest in the area of familial breast cancer including Professors Ian Campbell, John Hopper and Melissa Southey. These researchers have all played a role in improving testing mechanisms for BRAC1 and BRAC 2 genes as well as discovering more genes beyond these to help better determine the future risk of breast cancer for Australian men and women.

2017

“We are also now on the verge of developing tests to complement breast screening, to identify those people at greatest risk.”

NBCF BEHIND THE WORLD’S LARGEST BREAST CANCER GENETICS CASE STUDY

NBCF funded researcher Professor Georgia Chenevix-Trench from QIMR is one of the leaders in the world’s biggest ever genetic study of breast cancer, which collated and analysed data from 275,000 women across the globe. The study discovered 72 new genetic markers for the disease in the process, providing great scope for the development of a new predictive breast cancer test for women.

2017

“We think this strategy could delay or prevent breast cancer in women with an inherited BRCA1 gene mutation. A clinical trial has already begun to investigate this further.”

OSTEOPOROSIS TREATMENT MAY BE USED TO PREVENT BREAST CANCER

NBCF funded researcher Professor Geoff Lindemann from the Walter & Eliza Hall Institute discovers that an existing medication currently used to treat osteoporosis could potentially be used to prevent breast cancer in women carrying the faulty BRCA1 gene. This means that women with high genetic risk of breast cancer have the option to delay or prevent the disease without having to undergo a mastectomy.

2017

Launch of Circle of 10 Brisbane

NBCF hosts a launch event for a new ‘Circle of 10’ in Brisbane, Queensland. The launch was hosted by journalist Marie-Louise Theile. NBCF funded researcher Dr Kara Britt from the Peter MacCallum Cancer Centre in Victoria also gave a presentation about her research in the area of breast cancer prevention for young women.

2017

“These results are fantastic news for young women with breast cancer who require treatment with chemotherapy and want to have children. I have seen first-hand how young women with breast cancer have been able to go on to have healthy, happy babies following their cancer treatment, which is a wonderful result.”

NEW FERTILITY HOPE FOR YOUNG WOMEN WITH BREAST CANCER

NBCF funded Fellow Professor Kelly-Anne Phillips from the Peter MacCallum Cancer Centre played a key role in an Australian-led trial of more than 250 women worldwide conducted by Breast Cancer Trials that showed pre-menopausal women who received monthly injections of a drug called Goserelin were more likely to become pregnant after their breast cancer treatment. As a result, Goserelin has now been listed on the PBS, making it more affordable for Australian breast cancer patients.

2018

“Understanding the modifiable risk factors that influence whether women with BRCA1 or BRCA2 mutations go on to develop cancer will allow us to further improve advice and tailor effective cancer prevention strategies.”

STUDY FURTHER DEFINES RISK FOR BRAC1 and BRAC2

NBCF funded researcher Professor John Hopper from the University of Melbourne leads a game-changing study that provided a better understanding of the levels of risk of breast cancer for carriers of the BRCA1 and BRCA2 gene mutation. The study, which involved almost 10,000 women in Australia, the US and Europe over 20 years, found that those with the BRCA1 mutation had, on average, a 72 per cent risk of developing breast cancer by the age of 80.The risk of developing ovarian cancer for those women was on average 44 per cent. For those with the BRCA2 mutation, the risk of breast cancer was 69 per cent and the lifetime risk of ovarian cancer was 17 per cent.

2018

“Every day I see women newly diagnosed with breast cancer; some of them were clearly at increased risk and might have avoided their breast cancer had they had the opportunity to use a tool like iPrevent.”

NEW ONLINE TOOL PREDICTS BREAST CANCER RISK

NBCF funded Fellow Professor Kelly-Anne Phillips from the Peter MacCallum Cancer Centre launches a web-based tool called iPrevent® (www.iprevent.net,au) to help Australian women and their clinicians accurately know and appropriately manage their breast cancer risk.

2018

"This ground-breaking work is not only helpful for women from families with many cases of breast cancer, it will improve breast cancer risk prediction for all women. It also paves the way development of epigenetic therapeutics for breast cancer."

STUDY DISCOVERS FAMILIAL BREAST CANCER NOT ONLY INHERITED GENETICALLY

Researchers at the University of Melbourne, led by NBCF funded researcher Professor Melissa Southey, identified 24 previously unknown epigenetic changes that alter a woman's risk of breast cancer and can be passed down through generations without involving changes in the DNA sequence of genes.

As part of the study, Professor Southey looked at 210 people from 25 multiple-case breast cancer families. They identified 24 previously unknown epigenetic changes that alter a woman's risk of breast cancer and can be passed down through generations without involving changes in the DNA sequence of genes.

2018

INNOVATION HELPS HIT BREAST CANCER BULLSEYE

NBCF funded researcher Associate Professor Kristofer Thurecht, from the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Queensland University conducted a ground-breaking research project showing how a combination of chemistry and Magnetic Resonance Imaging and other scans can discern whether drugs to treat cancer like chemotherapy are heading to precisely the right place and at what rate the drugs are getting to the tumour.

His developments are important in the treatment of many cancers, including breast, and will potentially take cancer treatments a step closer to personalised medicine, with drug regimes tailored to suit each individual patient.

2018

“The gold nanoparticle technology is easy to use and extremely sensitive to CTC diversity — it can detect multiple types simultaneously down to as few as 10 CTCs in a 1 millilitre blood sample. We saw dramatic changes during treatment for all patients studied."

NEW BLOOD TEST HELPS TRACK BREAST CANCER SPREAD AND GUIDE TREATMENT

Professor Matt Trau from the University of Queensland, funded by NBCF since 2008, develops innovative blood test technology using gold nanoparticles to help track breast cancer spread and better determine the patient’s response to treatment. The technology, first tested in melanoma cells, monitors the diversity of individual cancer cells circulating in the body, also known as Circulating Tumour Cells (CTCs).

Ultimately, the new test will help clinicians guide breast cancer therapy in real-time and ascertain how and why treatment resistance occurs.

2018

GO PINK LAUNCHES

Building on the success of Real Men Wear Pink campaign, NBCF re-launches it as Go Pink, challenging all the men, women, girls and boys of Australia to GO PINK for breast cancer research during the week of 18-24 June.

2018

PINK RIBBON BREAKFAST CAMPAIGN 16TH ANNIVERSARY

The 16th anniversary of the Pink Ribbon Breakfast campaign.

2018

CIRCLE OF 10 MELBOURNE LAUNCHES

NBCF launches its Circle of 10 initiative in Melbourne at a special event hosted by the Director of the Bank of Melbourne Private at the Sofitel Hotel. Guests learned more about the work of Professor Sherene Loi, from the Peter MacCallum Cancer Centre in Victoria, in the areas of genomics and immunotherapy.

2030

OUR ASPIRATIONAL GOAL

Zero deaths from breast cancer.